Eye Health America

Eye Health America

Eye Health America formed in 2018 when Dallas-based private equity firm Latticework Capital partnered with CEO Rod Roeser to acquire and integrate ophthalmology and optometry practices. The platform targets the Southeastern US, where demographic tailwinds — an aging population with high cataract and glaucoma incidence — support sustained procedure volume. The firm does not disclose its total deployment or asset base. Eye Health America acquires majority stakes in established practices, leaving clinical and operational physicians with meaningful minority ownership. It covers comprehensive ophthalmology, cataract surgery, glaucoma treatment, retina care, and optical retail. The firm's model adds shared back-office functions — billing, HR, IT, marketing — while physicians retain autonomy over medical decisions. Known affiliate practices have included The Eye Associates in Bradenton, Florida, and Clemson Eye in South Carolina, among other regional groups. Latticework Capital, the financial sponsor, manages roughly $345 million across its first fund as of 2018 public records and raised additional commitments for later vintages. Eye Health America represents one of several healthcare-services platforms in Latticework's portfolio. The firm's leadership team blends operational healthcare executives with private equity professionals; Rod Roeser previously held senior roles at ophthalmology and dental services organizations before launching the platform. What distinguishes Eye Health America is its explicit sponsor-backed roll-up architecture rather than a family-office or physician-owned management services organization. This structure aligns Latticework's capital with physician-partners who receive both cash at close and ongoing equity in the platform, a liquidity path that traditional hospital-employed models rarely offer.